XML 25 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statement of Equity - USD ($)
$ in Thousands
Total
Common shares
Preferred shares
Additional paid-in capital
Deficit
AOCI
Non- controlling interests
Beginning Balance at Dec. 31, 2019 $ 4,406,595 $ 4,017,044 $ 184,299 $ 50,579 $ (367,107) $ (9,761) $ 531,541
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 193,605       222,422   (28,817)
Effect of redeemable non-controlling interests not included in equity (note 14) (3,684)           (3,684)
OCI (48,379)         (44,265) (4,114)
Dividends declared and distributions to non-controlling interests (151,847)       (136,811)   (15,036)
Dividends and issuance of shares under dividend reinvestment plan 0 25,822     (25,822)    
Contributions received from non-controlling interests (note 3(a) and (c)) 3,371           3,371
Common shares issued upon conversion of convertible debentures 12 12          
Common shares issued upon public offering, net of cost 118,300 118,300          
Common shares issued under employee share purchase plan 1,958 1,958          
Share-based compensation 12,509     12,509      
Common shares issued pursuant to share-based awards (9,111) 18,229   (11,254) (16,086)    
Ending Balance at Jun. 30, 2020 4,523,329 4,181,365 184,299 51,834 (323,404) (54,026) 483,261
Beginning Balance at Dec. 31, 2019 4,406,595 4,017,044 184,299 50,579 (367,107) (9,761) 531,541
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
OCI (13,437)            
Ending Balance at Dec. 31, 2020 5,662,190 4,935,304 184,299 60,729 45,753 (22,507) 458,612
Beginning Balance at Mar. 31, 2020 4,204,068 4,050,902 184,299 41,332 (521,314) (54,495) 503,344
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 272,978       286,219   (13,241)
Effect of redeemable non-controlling interests not included in equity (note 14) (1,637)           (1,637)
OCI 2,415         469 1,946
Dividends declared and distributions to non-controlling interests (84,143)       (76,992)   (7,151)
Dividends and issuance of shares under dividend reinvestment plan 0 8,871     (8,871)    
Common shares issued upon conversion of convertible debentures 118,300 118,300          
Common shares issued under employee share purchase plan 1,165 1,165          
Share-based compensation 11,056     11,056      
Common shares issued pursuant to share-based awards (873) 2,127   (554) (2,446)    
Ending Balance at Jun. 30, 2020 4,523,329 4,181,365 184,299 51,834 (323,404) (54,026) 483,261
Beginning Balance at Dec. 31, 2020 5,662,190 4,935,304 184,299 60,729 45,753 (22,507) 458,612
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 81,565       117,169   (35,604)
Effect of redeemable non-controlling interests not included in equity (note 14) (1,873)           (1,873)
OCI (25,250)         (27,179) 1,929
Dividends declared and distributions to non-controlling interests (171,971)       (158,604)   (13,367)
Dividends and issuance of shares under dividend reinvestment plan 0 46,208     (46,208)    
Contributions received from non-controlling interests (note 3(a) and (c)) 1,036,471     6,919   (6,371) 1,035,923
Common shares issued upon conversion of convertible debentures 16 16          
Common shares issued upon public offering, net of cost 261,228 261,228          
Contract adjustment payments (note 7(a)) (222,378)     (62,240) (160,138)    
Common shares issued under employee share purchase plan 2,572 2,572          
Share-based compensation 5,074     5,074      
Common shares issued pursuant to share-based awards (7,738) 6,480   (10,482) (3,736)    
Non-controlling interest assumed on asset acquisition (note 3(a)) 29,141           29,141
Ending Balance at Jun. 30, 2021 6,649,047 5,251,808 184,299 0 (205,764) (56,057) 1,474,761
Beginning Balance at Mar. 31, 2021 5,954,661 5,092,691 184,299 59,631 (40,330) (20,272) 678,642
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 84,902       103,222   (18,320)
Effect of redeemable non-controlling interests not included in equity (note 14) (910)           (910)
OCI (34,241)         (35,785) 1,544
Dividends declared and distributions to non-controlling interests (91,593)       (84,427)   (7,166)
Dividends and issuance of shares under dividend reinvestment plan 0 23,557     (23,557)    
Contributions received from non-controlling interests (note 3(a) and (c)) 820,971           820,971
Common shares issued upon conversion of convertible debentures 16 16          
Common shares issued upon public offering, net of cost 133,801 133,801          
Contract adjustment payments (note 7(a)) (222,378)     (62,240) (160,138)    
Common shares issued under employee share purchase plan 1,256 1,256          
Share-based compensation 3,513     3,513      
Common shares issued pursuant to share-based awards (951) 487   (904) (534)    
Ending Balance at Jun. 30, 2021 $ 6,649,047 $ 5,251,808 $ 184,299 $ 0 $ (205,764) $ (56,057) $ 1,474,761